Ayad Al‐Katib

4.6k citations

123 papers · 3.7k indexed · 1 hit paper · h-index 33

Impact in

Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment

Papers in

Genetics 53
- Chronic Lymphocytic Leukemia Research 51
Pathology and Forensic Medicine 46
- Lymphoma Diagnosis and Treatment 45

Co-authors: Ramzi M. Mohammad Amro Aboukameel George R. Pettit Nathan R. Wall Andrew R. Branagan Philip R. Greipp Jesús F. San Miguel Meletios Α. Dimopoulos
Journals: Blood (10 papers)Leukemia Research (8 papers)Journal of Clinical Oncology (6 papers)Anti-Cancer Drugs (4 papers)American Journal of Hematology (4 papers)
Partner nations: United States Canada France

In The Last Decade

Ayad Al‐Katib

122 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia 2003 · 621 citations

Peers

Countries citing papers authored by Ayad Al‐Katib

Since Specialization

Citations

This map shows the geographic impact of Ayad Al‐Katib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayad Al‐Katib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayad Al‐Katib more than expected).

Fields of papers citing papers by Ayad Al‐Katib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayad Al‐Katib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayad Al‐Katib. The network helps show where Ayad Al‐Katib may publish in the future.

Co-authors

The 25 scholars most cited alongside Ayad Al‐Katib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ayad Al‐Katib Line = papers co-authored together Ayad Al‐Katib links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy SHILAP Revista de lepidopterología ·Ayad Al‐Katib, Hussein Gaith, Dahlia Sano, Sayf Al‐Katib, Michelle Bonnett, Zyad Kafri	2020	1
2	Hematologic malignancies: newer strategies to counter the BCL-2 protein Journal of Cancer Research and Clinical Oncology ·Abdul Shukkur Ebrahim, Hussam Sabbagh, Allison Liddane, Ali Raufi, Mustapha Kandouz, Ayad Al‐Katib	2016	48
3	Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community setting Nuclear Medicine and Biology ·Tarik Hadid, Ali Raufi, Zyad Kafri, Mary Mandziara, John Kalabat, Susan Szpunar, Kleanthe Kolizeras, Mary Steigelman, Ayad Al‐Katib	2016	4
4	Tumor Lysis Syndrome as a Consequence of Chronic Lymphocytic Leukemia Treatment With Fludarabine and Rituximab Journal of Medical Cases ·Firas Yazigi, Anuradha Kolluru, Ayad Al‐Katib	2011	1
5	I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma Molecular Cancer ·Ayad Al‐Katib, Alan A Arnold, Amro Aboukameel, Angela Sosin, Peter G. Smith, Anwar N. Mohamed, Frances W.J. Beck, Ramzi M. Mohammad	2010	14
6	SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status Journal of Hematology & Oncology ·Ayad Al‐Katib, Yuan Sun, Anton Scott Goustin, Asfar S. Azmi, Ben Chen, Amro Aboukameel, Ramzi M. Mohammad	2009	26
7	Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model Molecular Cancer ·Alan A Arnold, Amro Aboukameel, Jianyong Chen, Dajun Yang, Shaomeng Wang, Ayad Al‐Katib, Ramzi M. Mohammad	2008	70
8	Outcome of Relapsed Non-Hodgkin's Lymphoma Patients After Allogeneic and Autologous Transplantation Cancer Investigation ·Ulka N. Vaishampayan, Chatchada Karanes, Wei Du, Mary Varterasian, Ayad Al‐Katib	2002	11
9	Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant Cancer Genetics and Cytogenetics ·Anwar N. Mohamed, Margarita Palutke, Leopoldo Eisenberg, Ayad Al‐Katib	2001	56
10	Effects of Combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines Anti-Cancer Drugs ·Sanaa Nabha, Nathan R. Wall, Ramzi M. Mohammad, George R. Pettit, Ayad Al‐Katib	2000	34
11	Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts. PubMed ·Ayad Al‐Katib, Mitchell R. Smith, W S Kamanda, George R. Pettit, Mohammed Hamdan, A.N. Mohamed, Bhadrani Chelladurai, Ramzi M. Mohammad	1998	58
12	Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Journal of Clinical Oncology ·Mary Varterasian, Ramzi M. Mohammad, D. Eilender, Kim Hulburd, Dorothy H. Rodriguez, Philip A. Pemberton, James M. Pluda, M. Dan, George R. Pettit, B D Chen, Ayad Al‐Katib	1998	99
13	Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis Leukemia ·Andrea König, Thomas Menzel, S Lynen, Laura Wrazel, Anders Rosén, Ayad Al‐Katib, Elizabeth Raveché, JL Gabrilove	1997	141
14	Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma Leukemia Research ·Ramzi M. Mohammad, Hariharan Diwakaran, Auday Maki, Ashraf M. Emara, George R. Pettit, Bruce G. Redman, Ayad Al‐Katib	1995	49
15	Bone marrow necrosis in lymphoma studied by magnetic resonance imaging American Journal of Hematology ·David E. Weissman, William Negendank, Ayad Al‐Katib, Mitchell R. Smith	1992	26
16	Expression of a New Cellular Protein by Monocytoid B-Lymphocytes Differentiated from the Acute Lymphoblastic Leukemia Cell Line (REH) Leukemia & lymphoma ·Ramzi M. Mohammad, Carl R. Clark, Terry Maloney, Ben D.‐M. Chen, Ayad Al‐Katib	1991	4
17	Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations. Radiology ·William Negendank, Ayad Al‐Katib, Chatchada Karanes, Mitchell R. Smith	1990	70
18	Detection of intracytoplasmic immunoglobulin by flow cytometry in B-cell malignancies. Journal of Histochemistry & Cytochemistry ·Ricardo H. Bardales, Ayad Al‐Katib, Alfredo Carrato, Benjamín Koziner	1989	17
19	Establishment and characterization of a human lymphoma cell line (WSU-NHL) with 14;18 translocation Leukemia Research ·Anwar N. Mohamed, Ayad Al‐Katib	1988	14
20	Phenotypic changes induced by recombinant interferon-gamma (r-IFN-γ) therapy in a case of chronic lymphocytic leukemia (CLL): Correlation with in vitro induction Proceedings of the American Association for Cancer Research ·Ayad Al‐Katib, Saroj Vadhan‐Raj, Susan E. Krown	1985	1

About Ayad Al‐Katib

Ayad Al‐Katib is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Immunology, having authored 123 papers that have together received 3.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (51 papers), Lymphoma Diagnosis and Treatment (45 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Acute Lymphoblastic Leukemia research (17 papers), Glycosylation and Glycoproteins Research (16 papers), Cancer-related Molecular Pathways (13 papers), Cell death mechanisms and regulation (12 papers) and Ubiquitin and proteasome pathways (12 papers). The work is most often cited by research in Genetics (1.2k citations), Pathology and Forensic Medicine (1.1k citations), Hematology (499 citations), Oncology (1.1k citations) and Immunology (726 citations). Ayad Al‐Katib has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Ramzi M. Mohammad, Ramzi M. Mohammad, Amro Aboukameel, George R. Pettit, Nathan R. Wall, Andrew R. Branagan, Philip R. Greipp, Jesús F. San Miguel, Meletios Α. Dimopoulos and Benjamín Koziner. Their work appears in journals such as Blood, Leukemia Research, Journal of Clinical Oncology, Anti-Cancer Drugs and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact